These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31263883)

  • 1. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.
    Krogager ML; Torp-Pedersen C; Mortensen RN; Køber L; Gislason G; Søgaard P; Aasbjerg K
    Eur Heart J; 2017 Jan; 38(2):104-112. PubMed ID: 28158516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
    Thind M; Crijns HJ; Naccarelli GV; Reiffel JA; Corp Dit Genti V; Wieloch M; Koren A; Kowey PR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1022-1030. PubMed ID: 32083368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal serum potassium levels and 6-month all-cause mortality in patients co-treated with antipsychotic and diuretic drugs - A Danish register-based cohort study.
    Marcussen M; Polcwiartek C; Mills EHA; Jirback F; Bylin P; Torp-Pedersen C; Søgaard P; Kragholm K
    Eur Neuropsychopharmacol; 2018 Sep; 28(9):1006-1014. PubMed ID: 30017260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium.
    Krogager ML; Søgaard P; Torp-Pedersen C; Bøggild H; Lee CJ; Bonde A; Thomassen JQ; Gislason G; Pareek M; Kragholm K
    BMC Cardiovasc Disord; 2020 Aug; 20(1):386. PubMed ID: 32838735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
    Dalgaard F; Pallisgaard JL; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH
    Heart Rhythm; 2019 Sep; 16(9):1348-1356. PubMed ID: 31125673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
    Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
    Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
    Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Mild Hypokalemia in Terms of Death and Stroke in the General Population-A Prospective Population Study.
    Mattsson N; Nielsen OW; Johnson L; Prescott E; Schnohr P; Jensen GB; Køber L; Sajadieh A
    Am J Med; 2018 Mar; 131(3):318.e9-318.e19. PubMed ID: 29024624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Potassium Levels and Short-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.
    Ma W; Liang Y; Zhu J; Yang Y; Tan H; Yu L; Gao X; Feng G; Li J
    Angiology; 2016 Sep; 67(8):729-36. PubMed ID: 26626107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum potassium levels with mortality in chronic heart failure patients.
    Aldahl M; Jensen AC; Davidsen L; Eriksen MA; Møller Hansen S; Nielsen BJ; Krogager ML; Køber L; Torp-Pedersen C; Søgaard P
    Eur Heart J; 2017 Oct; 38(38):2890-2896. PubMed ID: 29019614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
    Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
    Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial.
    Tazmini K; Fraz MSA; Nymo SH; Stokke MK; Louch WE; Øie E
    Am Heart J; 2020 Mar; 221():114-124. PubMed ID: 31986288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope.
    Dalgaard F; Pallisgaard JL; Numé AK; Lindhardt TB; Gislason GH; Torp-Pedersen C; Ruwald MH
    J Am Geriatr Soc; 2019 Oct; 67(10):2023-2030. PubMed ID: 31339174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.